Dr. Shayman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 East Medical Center Dr
University Hospital - Im Nephrology Inpatient
Ann Arbor, MI 48109Phone+1 734-888-2871- Is this information wrong?
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1985 - 1985- Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1983 - 1984
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1980 - 1983
- Washington University in St. Louis School of MedicineClass of 1980
Certifications & Licensure
MI State Medical License 1986 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1994
- Fellow (ASNF) American Society of Nephrology
Publications & Presentations
PubMed
- Moving the Needle: Accelerating Drug Discovery in Nephrology.James A Shayman> ;Journal of the American Society of Nephrology. 2023 Mar 1
- 1 citationsFunctional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1.Jonathan M Shillingford, James A Shayman> ;American Journal of Physiology. Renal Physiology. 2023 Apr 1
- Inhibitors of Glucosylceramide Synthase.James A Shayman, Vania Hinkovska-Galcheva, Liming Shu> ;Methods in Molecular Biology. 2023 Jan 1
- Join now to see all
Press Mentions
Protalix’s Phase III Asset for Fabry Could Struggle to Demonstrate Superiority over Fabrazyme but Immunogenicity Benefits Support Regulatory Chances, Experts SayFebruary 5th, 2021
Sanofi Pivotal Trial to Target Driver of Cyst Growth in PKDNovember 12th, 2018
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis from the HALT-PKD TrialsJanuary 4th, 2018
Grant Support
- Lysosomal Phospholipase A2 In Autoimmune DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
- The Pharmacological Treatment Of Fabry DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- The Pharmacologic Treatment Of Fabry DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2008
- Glycosphingolipids In Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
- Glycosphingolipid And Renal CarcinomaNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
- Sphingolipids And Polycystic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1997
- Renal Polyol MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1994
- Peptide Hormone Stimulated Inositol MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1989
- Peptide Hormone Stimulated Inositol MetabolismNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Professional Memberships
- Fellow
Hospital Affiliations
University of Michigan Medical CenterAnn Arbor, Michigan
Veterans Affairs Ann Arbor Healthcare SystemAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
